Identification of a novel single-stranded DNA fragment associated with human hepatitis

Journal of Infectious Diseases

Volumn 193, Issue 8, 2006, Pages 1089-1097

  Yeh, Chau Ting ^a   Tsao, Mei Lin ^a   Lin, Ying Chun ^a   Tseng, I Chu ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ANTIGEN; CESIUM CHLORIDE; DNA FRAGMENT; NUCLEASE S1; SINGLE STRANDED DNA;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CHROMOSOME; CONTROLLED STUDY; DENSITY; DNA DETERMINATION; DNA SEQUENCE; HEPATITIS B; HEPATITIS C; HEPATITIS NON A TO E; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LIVER CELL; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OPEN READING FRAME; PEPTIDE SYNTHESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS PARTICLE;

ADULT; AGED; AMINO ACID SEQUENCE; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BASE SEQUENCE; BIOPSY; CASE-CONTROL STUDIES; CLONING, MOLECULAR; DNA, VIRAL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEPATITIS; HEPATITIS VIRUSES; HUMANS; LIVER; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 33645758215     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/501474     Document Type: Article

References (20)

1. Dienstag JL, Alter HJ. Non-A, non-B hepatitis: evolving epidemiologic and clinical perspective. Semin Liver Dis 1986; 6:67-81.
2. Reyes GR, Baroudy BM. Molecular biology of non-A, non-B hepatitis agents: hepatitis C and hepatitis E viruses. Adv Virus Res 1991; 40:57-102.
3. Chu CM, Lin SM, Hsieh SY, et al. Etiology of sporadic acute viral hepatitis in Taiwan: the role of hepatitis C virus, hepatitis E virus and GB virus-C/hepatitis G virus in an endemic area of hepatitis A and B. J Med Virol 1999; 58:154-9.
4. Chu CM, Sheen IS, Liaw YF. The role of hepatitis C virus in fulminant viral hepatitis in an area with endemic hepatitis A and 14. Gastroenterology 1994; 107:189-95.
5. Kodali VP, Gordon SC, Silverman AL, McCray DG. Cryptogenic liver disease in the United States: further evidence for non-A, non-B, and non-C hepatitis. Am J Gastroenterol 1994; 89:1836-9.
6. Romeo R, Pol S, Demeret C, et al. Evidence of non-A, non-B, non-C infection in chronic hepatitis by polymerase chain reaction testing for hepatitis B and C viruses. J Hepatol 1995; 22:125-9.
7. Van Thiel DH, Gavaler JS, Baddour N, Friedlander L, Wright HI. Treatment of putative non-A, non-B, non-C hepatitis with alpha interferon: a preliminary trial. J Okla State Med Assoc 1994; 87:364-8.
8. Stapleton JT. GB virus type C/hepatitis G virus. Semin Liver Dis 2003; 23:137-48.
9. Cossart Y. TTV - a virus searching for a disease. J Clin Virol 2000; 17:1-3.
10. Akiba I, Umemura T, Alter HJ, Kojiro M, Tabor E. SEN virus: epidemiology and characteristics of a transfusion-transmitted virus. Transfusion 2005; 45:1084-8.
11. Hammel P, Marcellin P, Martinot-Peignoux M, et al. Etiology of chronic hepatitis in France: predominant role of hepatitis C virus. J Hepatol 1994; 21:618-23.
12. Thiers V, Lunel F, Valla D, et al. Post-transfusional anti-HCV-negative non-A non-B hepatitis (II) serological and polymerase chain reaction analysis for hepatitis C and hepatitis B viruses. J Hepatol 1993; 18:34-9.
13. Liaw YF, Yang SS, Chen TJ, Chu CM. Acute exacerbation in hepatitis B e antigen positive chronic type B hepatitis: a clinicopathological study. J Hepatol 1985; 1:227-33.
14. Brunt EM. Nonalcoholic steatohepatitis. Semin Liver Dis 2004; 24:3-20.
15. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346:1221-31.
16. Liaw YF. Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology 1995; 22:1101-8.
17. Liaw YF, Chen YC, Sheen IS, Chien RN, Yeh CT, Chu CM. Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Gastroenterology 2004; 126:1024-9.
18. Yeh CT, Lu SC, Tseng IC, et al. Antisense overexpression of BMAL2 enhances cell proliferation. Oncogene 2003; 22:5306-14.
19. Yeh CT, Chien RN, Chu CM, Liaw YF. Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy. Hepatology 2000; 31:1318-26.
20. Yeh CT, Lu SC, Chu CM, Liaw YF. Molecular cloning of a defective hepatitis C virus genome from the ascitic fluid of a patient with hepatocellular carcinoma. J Gen Virol 1997; 78:2761-70.